Delivery Order SPE2DB22D3010-SPE2DB24FP2AU
- Not listed
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $2,441.64 order is for the provision of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication, with a performance period ending on March 19, 2024. Amerisourcebergen Drug Corp, the prime contractor, holds an Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp provides for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used for the emergency treatment of known or suspected opioid overdose. The $2,926.08 firm fixed-price delivery order has a completion date of March 7, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,457.64, is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The contract is a firm-fixed-price delivery order, and does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The delivery order, valued at $1,096.63, is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical care medical product, to support military treatment programs and facilities. The delivery order was issued under an Indefinite Delivery Contract (IDC) held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,392.27 fixed-price delivery order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdose. The contract has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,114.26 firm fixed price delivery order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication, with a performance period through March 15, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,400.64 fixed-price contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities for...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $3,524.39 order is for NARCAN 4 MG NASAL SPRAY 2S, a critical pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors identified. The order is placed under an Indefinite Delivery Contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential...
- This is a delivery order award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for 4,559,524,860 units of NARCAN 4 mg nasal spray, a critical medication for the treatment of opioid overdoses. The award, valued at $17,163.42, is under a firm-fixed-price contract type and has a period of performance through January 9, 2023. This award is not designated as a set-aside contract. Amerisourcebergen, as a major...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,733.71, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The contract is a delivery order with a firm fixed price and an ultimate completion date of January 8, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB24FP2AUDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,350.17 award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. The delivery order was issued under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. No set-aside designation was used for this specific award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 4/1/24 |